DT Investment Partners, LLC
Position in NTLA — Intellia Therapeutics, Inc.
CIK 1537621
CHADDS FORD, PA
Position in NTLA
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$169
+$41 QoQ
Shares Held
10
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#318
of 329 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NTLA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026DT Investment Partners, LLC holds $38,645 across 6 Biotechnology names. NTLA ranks #6 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
44 | $21,856 | |
| 2 | BMRN |
Biomarin Pharmaceutical Inc
|
168 | $9,612 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
10 | $6,235 | |
| 4 | CRSP |
CRISPR Therapeutics AG
|
11 | $599 | |
| 5 | EDIT |
Editas Medicine, Inc.
|
54 | $174 | |
| 6 | NTLA |
Intellia Therapeutics, Inc.
This page
|
10 | $169 |
All Filings in NTLA
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $169 | 10 | Shares | Sole | 2026-07-27 | |
| 2026-03-31 | $128 | 10 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $89 | 10 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $172 | 10 | Shares | Sole | 2025-10-22 | |
| 2025-06-30 | $93 | 10 | Shares | Sole | 2025-07-22 | |
| 2025-03-31 | $71 | 10 | Shares | Sole | 2025-04-29 | |
| 2024-12-31 | $116 | 10 | Shares | Sole | 2025-01-30 | |
| 2024-09-30 | $205 | 10 | Shares | Sole | 2024-10-23 | |
| No filing history on record for this holder in this stock. | ||||||